Latest Whitepapers

Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.

The EU GMP Annex 1 provides specific guidance on the manufacture of sterile medicinal products. Though it is a European guide for manufacturing, EU GMP Annex 1’s impact is global. So how does the latest revision affect you?

Rather than choosing between the detail of single-cell RNA sequencing and the in situ capabilities of conventional immunohistochemistry, spatial phenotyping allow you to visualize and quantify dozens of biomarkers in a single tissue sample while maintaining cellular and sub-cellular detail.

Recent technological advancements have made single-cell sequencing an increasingly powerful tool for understanding biology and cellular function, disease diagnosis, therapy response prediction, and treatment selection.

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.

Biofuels have garnered increased attention due to the economic and environmental concerns associated with petroleum-based fuel.

CRISPR/Cas9 has revolutionized the field of genome editing by increasing the efficiency, multiplex capability and ease of use like never before.

Download this whitepaper to explore considerations when selecting a harvest technology such as sustainability, time and cost as well as space and scale.

In 2012, the Harvard Brain Tissue Resource Center lost 150 of its stored frozen brain samples, including one third of the world’s largest collection of autism brain tissue.

To support successful laboratory functions, access to a modern informatics suite is essential, and this can be either on-premise or a cloud-hosted solution. There is however a third option, known as Software-as-a-Service (SaaS).